E. V. Helvoort

Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a rondomized observer blinded clinical trial

J. Bijlsma, F. Lafeber, S. Mastbergen, 2017 .

Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a rondomized observer blinded clinical trial

J. Bijlsma, F. Lafeber, S. Mastbergen, 2017 .

SAT0508 Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a randomized observer blinded clinical trial

J. Bijlsma, J. V. Laar, K. Coeleveld, 2017 .

Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study

M. Tryfonidou, N. Eijkelkamp, S. Mastbergen, 2019, PloS one.